Pharmacologic treatments for covid-19 patients

Otilimab vs Placebo


Hospitalized patients

Forest plots
(last update: 2022-10-14)

Summary of findings
(last update: 2022-10-23)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=359

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
NCT04376684
OSCAR
Patel J, medRxiv, 2021
Full text
Commentary
Commentary
Private

Otilimab

Placebo

RCT Patients with confirmed COVID-19 (severe-critical) admitted to 108 centers in 17 countries N=806
Some concerns
Details

Full description

NCT04376684
OSCAR
NCT04376684, Unpublished, 2022
Full text
Not reported/unclear

Otilimab

Placebo

RCT Patients with confirmed COVID-19 (severe-critical) admitted to 120 centers in 19 countries N=350
Some concerns
Details

Full description